Saifuyuzu
4892.TPharmaceutical
Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Shizuka Akieda | 7.31% |
| Masahiro Sanjo | 6.74% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| SBI Ventures Two Co., Ltd. | 4.64% |
| SBI Shinsei Bank, Limited | 2.24% |
| SBI SECURITIES Co., Ltd. | 0.83% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| SBI Shinsei Bank, Limited2024-07-02 · amended | 2.74% | no change |
| SBI SECURITIES Co., Ltd.2024-07-02 · amended | 3.22% | -0.16pp |
| SBI Ventures Two Co., Ltd2024-07-02 · amended | 6.03% | no change |
| SBI Shinsei Bank, Limited2024-06-05 · amended | 2.74% | -0.08pp |
| SBI SECURITIES Co., Ltd.2024-06-05 · amended | 3.38% | +0.72pp |
| SBI Ventures Two Co., Ltd.2024-06-05 · amended | 6.03% | -0.18pp |
| SBI SECURITIES Co., Ltd.2024-03-18 · amended | 2.66% | +0.23pp |
| SBI Shinsei Bank, Limited2024-03-18 · amended | 2.82% | no change |
| SBI Ventures Two Co., Ltd.2024-03-18 · amended | 6.21% | no change |
| SBI SECURITIES Co., Ltd.2024-02-15 · amended | 2.43% | new |
| SBI Shinsei Bank, Limited2024-02-15 · amended | 2.82% | new |
| SBI Ventures Two Co., Ltd.2024-02-15 · amended | 6.21% | new |
| Shizuka Akieda2024-01-23 | 6.88% | new |
| Masahiro Sanjo2024-01-23 | 5.48% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.